Untreated type 1 diabetes is a fatal condition due to diabetic ketoacidosis. Poorly controlled type 1 diabetes is a risk factor for chronic complications such as blindness, renal failure, foot amputations, and heart attacks. Intensive glycemic control has been shown to decrease the incidence of microvascular and macrovascular disease in type 1 diabetes, and the decreased incidence of macrovascular disease has been shown to persist for up to 30 years.[159]White NH, Sun W, Cleary PA, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010 May;59(5):1244-53.
http://diabetes.diabetesjournals.org/content/59/5/1244.long
http://www.ncbi.nlm.nih.gov/pubmed/20150283?tool=bestpractice.com
[160]Nathan DM, Genuth S, Lachin J; The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86.
https://www.nejm.org/doi/10.1056/NEJM199309303291401
http://www.ncbi.nlm.nih.gov/pubmed/8366922?tool=bestpractice.com
[161]Pop-Busui RL, Low PA, Waberski BH, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC). Circulation. 2009 Jun 9;119(22):2886-93.
https://www.ahajournals.org/doi/full/10.1161/circulationaha.108.837369
http://www.ncbi.nlm.nih.gov/pubmed/19470886?tool=bestpractice.com
[162]Nathan DM, Zinman B, Cleary PA, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications experience (1983-2005). Arch Intern Med. 2009 Jul 27;169(14):1307-16.
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/724752
http://www.ncbi.nlm.nih.gov/pubmed/19636033?tool=bestpractice.com
[163]Nathan DM, Cleary PA, Backlund JY, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005 Dec 22;353(25):2643-53.
https://www.nejm.org/doi/10.1056/NEJMoa052187
http://www.ncbi.nlm.nih.gov/pubmed/16371630?tool=bestpractice.com
[164]Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC Study 30-year follow-up. Diabetes Care. 2016 May;39(5):686-93.
http://care.diabetesjournals.org/content/39/5/686.long
http://www.ncbi.nlm.nih.gov/pubmed/26861924?tool=bestpractice.com
[
]
How does intensive glucose control compare with conventional glucose control in adults with type 1 diabetes mellitus?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1025/fullShow me the answer Even a few years of intensive glucose control translate to reduced rates of microvascular and macrovascular complications 10 years later.[160]Nathan DM, Genuth S, Lachin J; The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86.
https://www.nejm.org/doi/10.1056/NEJM199309303291401
http://www.ncbi.nlm.nih.gov/pubmed/8366922?tool=bestpractice.com
[165]Albers JW, Herman WH, Pop-Busui R, et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 2010 May;33(5):1090-6.
http://care.diabetesjournals.org/content/33/5/1090.long
http://www.ncbi.nlm.nih.gov/pubmed/20150297?tool=bestpractice.com
The American Diabetes Association recommends maintaining glycosylated hemoglobin (HbA1c) <7% to prevent complications in many nonpregnant adults, adolescents, and children with type 1 diabetes.[1]American Diabetes Association. Standards of care in diabetes - 2024. Diabetes Care. 2024 Jan;47(1):S1-321.
https://diabetesjournals.org/care/issue/47/Supplement_1
Less stringent goals may be appropriate for very young children; older adults; people with a history of severe or frequent hypoglycemia; and those with limited life expectancies, advanced microvascular or macrovascular complications, or comorbid conditions.[1]American Diabetes Association. Standards of care in diabetes - 2024. Diabetes Care. 2024 Jan;47(1):S1-321.
https://diabetesjournals.org/care/issue/47/Supplement_1
Overall, cardiovascular disease is the major cause of death and a major cause of morbidity for patients with diabetes. One analysis of patients with type 1 diabetes diagnosed before the age of 15 years found that the leading cause of death before the age of 30 years was acute complications of diabetes. After the age of 30 years cardiovascular disease was predominant, although death attributable to acute complications was still important in this age group.[166]Gagnum V, Stene LC, Jenssen TG, et al. Causes of death in childhood-onset type 1 diabetes: long-term follow-up. Diabet Med. 2017 Jan;34(1):56-63.
http://www.ncbi.nlm.nih.gov/pubmed/26996105?tool=bestpractice.com
Older adults with diabetes need increased caregiver input and have higher rates of functional disability, accelerated muscle loss, and coexisting sickness (e.g., hypertension, stroke, heart, and kidney disease) and premature death than those without diabetes.[1]American Diabetes Association. Standards of care in diabetes - 2024. Diabetes Care. 2024 Jan;47(1):S1-321.
https://diabetesjournals.org/care/issue/47/Supplement_1
They are also at increased risk for several common geriatric syndromes.[1]American Diabetes Association. Standards of care in diabetes - 2024. Diabetes Care. 2024 Jan;47(1):S1-321.
https://diabetesjournals.org/care/issue/47/Supplement_1
With careful planning and adequate treatment, most individuals of childbearing potential with type 1 diabetes can have successful pregnancies.